Strain improvement for fermentation and biocatalysis processes by genetic engineering technology.

Area of Science:

• Metabolic Engineering
• Biotechnology
• Enzyme Engineering

Background:

• Cloning of the actinorhodin biosynthetic gene cluster 20 years ago marked a milestone.
• Subsequent isolation of numerous antibiotic biosynthetic gene clusters and technological breakthroughs have enabled rational design of novel metabolites.
• Current advancements focus on optimizing secondary metabolite production.

Purpose of the Study:

• To explore the application of modern biotechnology tools in enhancing secondary metabolite production.
• To discuss the future trajectory of metabolic pathway engineering and enzyme development.
• To highlight the increasing use of biocatalysts in chemical synthesis.

Main Methods:

• High-throughput DNA sequencing and DNA microarray techniques for identifying regulatory mechanisms and monitoring gene expression.
• Polymerase chain reaction (PCR) technologies for protein engineering.
• DNA shuffling for generating enzymes with improved properties.

Main Results:

• Accelerated rational application of metabolic pathway engineering for secondary metabolite overproduction.
• Development of new enzymes with enhanced stability, substrate specificity, reaction rates, and enantioselectivity.
• Increased use of whole cells or partially purified enzymes as catalysts in pharmaceutical and fine-chemical synthesis.

Conclusions:

• Modern biotechnology tools are revolutionizing the production of secondary metabolites and the development of novel enzymes.
• These advancements are paving the way for more efficient and sustainable chemical synthesis.
• The future promises continued innovation in biocatalysis and metabolic engineering for the 21st century.